Treatment Options and Surgical Decisions
At a Glance
For a presumed benign ovarian cystadenoma, follow-up ultrasound may be appropriate when imaging is reassuring and symptoms are absent. If surgery is needed, removing just the cyst can preserve ovarian tissue, while very large or suspicious cysts may require removal of the ovary.
Deciding how to treat a presumed ovarian cystadenoma involves balancing the symptoms you are experiencing with the potential risks of surgery. Because these tumors are generally benign, the goal of treatment is to relieve your discomfort and prevent complications like torsion while preserving as much healthy ovarian tissue as possible [1][2].
The Choice of Observation
If your cyst is asymptomatic and appears reassuringly benign on imaging (such as an O-RADS 2 or 3 score), your doctor may recommend expectant management (observation) [3][4].
Current research suggests this is a safe option for many presumed benign cysts. In a large study of over 3,000 women with benign-appearing cysts, the risk of a cyst turning out to be cancerous during follow-up was very low (less than 0.5%) [3].
- The Schedule: Monitoring typically involves follow-up ultrasounds to watch for changes in size or appearance. The exact schedule (e.g., at 3 months, 6 months, and annually) will depend on your age, the cyst’s morphology, and local guidelines [3].
- When to Stop Waiting: Surgery is usually considered if the cyst grows significantly, causes new pain, or begins to show suspicious features on an ultrasound [2]. Keep in mind that observation monitors a presumed benign mass; it does not establish that a persistent true cystadenoma will simply disappear.
Surgical Options: Saving the Ovary
When surgery is necessary, there are two primary types of procedures. The choice depends on your age, your desire for future children, and how much of the ovary is affected.
Ovarian Cystectomy
In a cystectomy, the surgeon carefully peels the cyst away from the healthy part of the ovary, leaving the rest of the organ intact [1].
- Best for: Children, adolescents, and premenopausal women who wish to preserve their fertility and hormone production [1][5].
- The Trade-off: While this saves the ovary, there is a small risk that a new cystadenoma could grow back in the same spot later. Research in specific surgical cohorts shows a recurrence rate of about 2.6% overall, though it may be slightly higher (around 10%) for the mucinous type [6].
- In Cases of Torsion: While torsion once routinely led to ovary removal, current management often emphasizes urgent detorsion (untwisting) and ovarian preservation with cystectomy, unless the tissue is clearly nonviable or malignancy is strongly suspected.
Oophorectomy (Salpingo-Oophorectomy)
In an oophorectomy, the entire ovary is removed. If the fallopian tube is also removed, it is called a salpingo-oophorectomy.
- Best for: Postmenopausal women, cases where the cyst has completely replaced the healthy ovarian tissue, or when there is substantial concern for malignancy [7][8].
Choosing the Surgical Approach
Your surgeon will also decide how to access the cyst. The “best” approach is the one that allows the mass to be removed safely while preventing its contents from spilling.
Laparoscopy (Minimally Invasive)
This involves small “keyhole” incisions and a camera. It is the preferred method for most benign cystadenomas because it results in less pain and a faster recovery [9].
- Specimen Bags: To prevent fluid from spilling into your abdomen, surgeons often place the cyst inside a sterile retrieval bag before removing it [10].
- Conversion Risk: In some cases, such as an 11% conversion rate seen in one study of laparoscopically managed adnexal masses, a surgeon may need to “convert” to an open surgery if they find severe scar tissue or if the cyst is too difficult to remove safely [11].
Laparotomy (Open Surgery)
An open surgery involves one larger incision. This is often planned for “giant” cystadenomas—such as those larger than 15–20 centimeters—or when there is a concern that the cyst might be cancerous [12][13].
- The Benefit of Open Surgery: It provides the surgeon with a better view and allows them to remove very large, heavy cysts intact, minimizing the risk of rupture [14].
Understanding Surgical Risks
While generally safe, surgeries for cystadenoma carry specific considerations:
- Cyst Spillage and PMP: You may have read that a ruptured mucinous cyst can cause pseudomyxoma peritonei (PMP), a serious condition where mucin-producing cells coat the abdomen. Be reassured that PMP most often arises from an appendiceal mucinous neoplasm. Rupture of an ordinary benign ovarian mucinous cystadenoma is exceedingly rarely the cause of PMP. However, surgeons still strictly avoid spillage during ovarian surgery, primarily to prevent the spread of unexpected borderline or malignant cells if the diagnosis changes after pathology review [15][16].
- Ovarian Reserve: Any surgery on the ovary can reduce your ovarian reserve (the quantity of follicles remaining). Studies often see a drop in Anti-Müllerian Hormone (AMH) levels after surgery, though the impact depends heavily on your baseline reserve and the extent of the surgery [17][18].
- Standard Risks: Like any pelvic surgery, there are risks of bleeding, infection, and the formation of adhesions that can cause long-term pelvic pain [11][9].
Common questions in this guide
When can an ovarian cystadenoma be watched instead of removed?
What is an ovarian cystectomy, and can it preserve fertility?
When is an oophorectomy or salpingo-oophorectomy recommended?
Is laparoscopy safe for ovarian cystadenoma, or will I need open surgery?
How can ovarian cystadenoma surgery affect fertility?
What happens if an ovarian cystadenoma causes ovarian torsion?
Does a ruptured mucinous ovarian cyst cause pseudomyxoma peritonei?
Get notified when new evidence is published on ovarian cystadenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
Mucinous Cystadenoma in Children and Adolescents.
Cowan RA, Haber EN, Faucz FR, et al.
Journal of pediatric and adolescent gynecology 2017; (30(4)):495-498 doi:10.1016/j.jpag.2017.02.001.
PMID: 28216128 - 2
Diagnosis and Management of Adnexal Masses.
Biggs WS, Marks ST
American family physician 2016; (93(8)):676-81.
PMID: 27175840 - 3
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.
Froyman W, Landolfo C, De Cock B, et al.
The Lancet. Oncology 2019; (20(3)):448-458 doi:10.1016/S1470-2045(18)30837-4.
PMID: 30737137 - 4
Management of the Adnexal Mass: Considerations for the Family Medicine Physician.
Bullock B, Larkin L, Turker L, Stampler K
Frontiers in medicine 2022; (9()):913549 doi:10.3389/fmed.2022.913549.
PMID: 35865172 - 5
Management of Recurrent Large Bilateral Benign Mucinous Cystadenomas of the Ovary: A Case Report.
Omura M, Sarkar RK, Sankar A
Journal of reproduction & infertility 2025; (26(1)):64-68 doi:10.18502/jri.v26i1.18783.
PMID: 40757036 - 6
Recurrence Rates for Pediatric Benign Ovarian Neoplasms.
Knaus ME, Onwuka AJ, Abouelseoud NM, et al.
Journal of pediatric and adolescent gynecology 2023; (36(2)):160-166 doi:10.1016/j.jpag.2022.11.006.
PMID: 36496105 - 7
Ovarian sparing surgery can be achieved for many pediatric patients with giant adnexal cystic masses.
McCauley CJ, Foote M, Laronda MM, et al.
Journal of pediatric surgery 2026; (61(3)):162871 doi:10.1016/j.jpedsurg.2025.162871.
PMID: 41389959 - 8
Case Report of a Large Ovarian Cyst in a Multiparous Woman: A Challenging Surgical Management.
Kasar IT, Alqarni AH, Miskeen E, et al.
Case reports in obstetrics and gynecology 2026; (2026()):2109088 doi:10.1155/crog/2109088.
PMID: 41810056 - 9
Trends in the Use of Minimally Invasive Adnexal Surgery in the United States.
Dioun S, Huang Y, Melamed A, et al.
Obstetrics and gynecology 2021; (138(5)):738-746 doi:10.1097/AOG.0000000000004577.
PMID: 34619737 - 10
Short- and long-term outcomes of intraoperative spillage during laparoscopic removal of benign ovarian cysts.
Hizkiyahu R, Yahav L, Yakovi S, et al.
Surgical endoscopy 2020; (34(9)):3883-3887 doi:10.1007/s00464-019-07154-6.
PMID: 31586249 - 11
Laparoscopic treatment of 1522 adnexal masses: an 8-year experience.
Grammatikakis I, Trompoukis P, Zervoudis S, et al.
Diagnostic and therapeutic endoscopy 2015; (2015()):979162 doi:10.1155/2015/979162.
PMID: 25762854 - 12
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report.
Sanna E, Madeddu C, Melis L, et al.
World journal of clinical cases 2020; (8(16)):3527-3533 doi:10.12998/wjcc.v8.i16.3527.
PMID: 32913859 - 13
Giant Ovarian Mucinous Tumor Managed by Transvaginal Drainage of Tumor Contents Followed by Laparoscopic Resection: A Case Report.
Mori S, Kato M, Murai T, et al.
Cureus 2026; (18(7)):e111960 doi:10.7759/cureus.111960.
PMID: 42544222 - 14
Giant mucinous ovarian cyst filling the abdominal cavity: clinical presentation, imaging findings, and surgical management.
Karakaya H, Gümüş M, Akarsu GD
BMC women's health 2026; (26(1)).
PMID: 42316207 - 15
Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries.
Yan F, Shi F, Li X, et al.
Cancer management and research 2020; (12()):7569-7578 doi:10.2147/CMAR.S264474.
PMID: 32904568 - 16
History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century.
Morera-Ocon FJ, Navarro-Campoy C
World journal of gastrointestinal surgery 2019; (11(9)):358-364 doi:10.4240/wjgs.v11.i9.358.
PMID: 31572561 - 17
Comparison of anti-mullerian hormone level in non-endometriotic benign ovarian cyst before and after laparoscopic cystectomy.
Amooee S, Gharib M, Ravanfar P
Iranian journal of reproductive medicine 2015; (13(3)):149-54.
PMID: 26000005 - 18
Comparison of the impact of single-port laparoscopic and conventional laparoscopic ovarian cystectomy on the ovarian reserve in adult patients with benign ovarian cysts.
Wang D, Liu H, Li D, et al.
Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy 2020; (29(4)):224-231 doi:10.1080/13645706.2019.1624575.
PMID: 31154886
This page provides general information about observation and surgery for ovarian cystadenoma for informational purposes only and does not constitute medical advice. Your gynecologic surgeon should tailor recommendations to your imaging, symptoms, fertility goals, and surgical risks.